Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma

22 Jul 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to MicroRNA in disease regulation
Share to Multiple Myeloma Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37499518
DOI: 10.1016/j.prp.2023.154704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miRNAs driving diagnosis, progression, and drug resistance in multiple myelomaPMID 37499518Read ↗

Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathwaysSemantic proximity Read ↗

Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple MyelomaSemantic proximity Read ↗

Molecular pathogenesis of multiple myeloma: basic and clinical updatesSemantic proximity Read ↗

IRF4 in multiple myeloma—Biology, disease and therapeutic targetSemantic proximity Read ↗

Roles of miRNA dysregulation in the pathogenesis of multiple myelomaSemantic proximity Read ↗

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistanceSemantic proximity Read ↗

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.Semantic proximity Read ↗

The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myelomaSemantic proximity Read ↗

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myelomaSemantic proximity Read ↗

Circulating microRNA expression is associated with genetic subtype and survival of multiple myelomaSemantic proximity Read ↗

The molecular characterization and clinical management of multiple myeloma in the post-genome eraSemantic proximity Read ↗

Role of micro-RNAs in drug resistance of multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.